Uluslararası HastaDuyurularİletişim
HACETTEPE ÜNİVERSİTESİHASTANELERİ
Randevu Al
TR
  1. Ana Sayfa
  2. Doktorlar
  3. Öğr. Gör. Dr. Nazire Pınar Acar Özen
Öğr. Gör. Dr. Nazire Pınar Acar Özen

Öğr. Gör. Dr.

Nazire Pınar Acar Özen

Nöroloji · Erişkin Hastanesi

Randevu Al

Yayınlar

Kaynak: Hacettepe Üniversitesi Akademik Veri Yönetim Sistemi (AVESİS) · Tüm yayınlar (34) ↗

Makaleler 25

  1. Structural brain correlates of alexithymia in MS: the impact of corpus callosum volume and lesion localizationACAR ÖZEN N. P., Cinar M., SALCI Y., Gormus M., KAYA K., GÖÇMEN R., et al.Acta Neurologica Belgica, cilt.126, sa.4, ss.1249-1257, 2026 (SCI-Expanded, Scopus)
  2. Differential safety profiles of disease-modifying therapies in MS: Age- and sex-based analysis from a real-world cohortErcan M. C., Cakan E., Gumus Y., Ozen N. P. A., Tuncer A., KARABUDAK R.Multiple Sclerosis and Related Disorders, cilt.111, 2026 (SCI-Expanded, Scopus)
  3. A Study on the Association of Ccrl2 Atypical Chemokine Receptor Polymorphism with the Disease Progression of Multiple Sclerosis in Turkish Patients: Insights From a Negative StudyACAR ÖZEN N. P., Horzum U., KARABUDAK R., Tuncer A.Noropsikiyatri Arsivi, cilt.63, ss.176-179, 2026 (SCI-Expanded, Scopus, TRDizin)
  4. Increased Myeloid-Derived Suppressor Cells in Newly Diagnosed Multiple Sclerosis: Immunophenotyping and Functional ValidationACAR ÖZEN N. P., Yanık H., Tuncer A.Noropsikiyatri Arsivi, cilt.63, ss.448-453, 2026 (SCI-Expanded, Scopus, TRDizin)
  5. Comparison of clinical features of aquaporin-4 positive neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein associated disorder (MOGAD), and double seronegative NMOSD - A single center experienceÇAKAN ERCAN M., Demirel E., ÇİMEN B., ACAR ÖZEN N. P., Colpak I., Karabudak R., et al.JOURNAL OF NEUROIMMUNOLOGY, cilt.403, 2025 (SCI-Expanded, Scopus)
  6. Lessons learned and paths forward: Navigating the social landscape of multiple sclerosis care in the second wave of COVID-19Ozen N. P. A., Cılızoğlu D., Toprak B., demirok n., SALCI Y., Karabudak R., et al.Turkish journal of neurology, cilt.31, sa.2, ss.213-223, 2025 (Scopus, TRDizin)
  7. Reliability and validity of the community balance and mobility scale in individuals with multiple sclerosisOzbas E., Balkan A. F., SALCI Y., AKYOL B., ACAR ÖZEN N. P., TUNCER M. A.ACTA NEUROLOGICA BELGICA, cilt.125, sa.2, ss.385-393, 2025 (SCI-Expanded, Scopus)
  8. Can serum C3/C4 complement ratio be used in the differential diagnosis of central nervous system demyelinating diseases?ÇAKAN ERCAN M., ÇİMEN B., ACAR ÖZEN N. P., SARA M. Y., KARABUDAK R., Tuncer A.MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.95, 2025 (SCI-Expanded, Scopus)
  9. Impact of cognitive fatigue on balance in individuals with multiple sclerosis without cognitive impairmentTuran K., Balkan A. F., Eroglu E. O., AKSOY S., ACAR ÖZEN N. P., Tuncer A., et al.NEUROLOGICAL RESEARCH, cilt.47, sa.3, ss.178-187, 2025 (SCI-Expanded, Scopus)
  10. Long-term Safety and Efficacy of Rituximab in Autoimmune Central Nervous System Disorders: Insights from a Single-Center CohortOzbek E. D., Acar N. P., ÇOLPAK IŞIKAY A. İ., Tan E., KARABUDAK R., TUNCER M. A.MULTIPLE SCLEROSIS JOURNAL, sa.3, ss.1102-1103, 2024 (SCI-Expanded, Scopus)
  11. Choroid Plexus Enlargement and Associated Thalamus Atrophy Initiate in Radiologically Isolated SyndromeOzbek E. D., Acar N. P., Gormus M., KAYA K., AKÇİÇEK E., Bachhuber F., et al.MULTIPLE SCLEROSIS JOURNAL, sa.3, ss.1251, 2024 (SCI-Expanded, Scopus)
  12. Impact of the MIND Diet on Oxidative Stress Markers in Patients with Relapsing-Remitting Multiple SclerosisATABİLEN B., Acar N. P., Polat M. B., PINAR A., TUNCER M. A., AKDEVELİOĞLU Y.MULTIPLE SCLEROSIS JOURNAL, sa.3, ss.1053-1054, 2024 (SCI-Expanded, Scopus)
  13. Exploring Cognitive Enhancements and Default Mode Network Connectivity in Relapsing-Remitting Multiple Sclerosis: Insights from a Prospective Study Investigating the MIND DietDEMİREL M., Dasgin H., Acar N. P., ÖZÇELİK EROĞLU E., ATABİLEN B., ERTUĞRUL A., et al.MULTIPLE SCLEROSIS JOURNAL, sa.3, ss.544, 2024 (SCI-Expanded, Scopus)
  14. Evaluation of Myeloid-Derived Suppressor Cells in Newly Diagnosed MS PatientsAcar N. P., Yanik H., ESENDAĞLI G., KARABUDAK R., TUNCER M. A.MULTIPLE SCLEROSIS JOURNAL, sa.3, ss.887-888, 2024 (SCI-Expanded, Scopus)
  15. Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE)Tuncer A., Kürtüncü M., Terzi M., UYGUNOĞLU U., Göncüoğlu C., Yüceyar A. N., et al.Turkish Journal of Medical Sciences, cilt.53, sa.1, ss.323-332, 2023 (SCI-Expanded, Scopus, TRDizin)
  16. Life After Tetra Hit: Anti-NMDAR Encephalitis After HSV Encephalitis in a NMOSD Coexistent with Sjogren's SyndromeAyvacioglu Cagan C., GÖÇMEN R., ACAR ÖZEN N. P., Tuncer A.NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, cilt.59, sa.2, ss.161-163, 2022 (SCI-Expanded, Scopus, TRDizin)
  17. Small Fiber Functionality in Patients with Diabetic Neuropathic PainÜNAL ÇEVİK I., ORHAN D., ACAR ÖZEN N. P., Mamak-Ekinci E. B.PAIN MEDICINE, cilt.22, sa.9, ss.2068-2078, 2021 (SCI-Expanded, Scopus)
  18. Factors Affecting Bone Mineral Density in Male Patients with Primary Progressive Multiple SclerosisArican A. C., Kutsal Y. G., Acar N. P., AKBIYIK F., KARAHAN S., KARABUDAK R.TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, cilt.26, sa.2, ss.115-120, 2020 (ESCI, Scopus, TRDizin)
  19. Two cases of primary leptomeningeal melanomatosis mimicking subacute meningitisASLAN S., GÖÇMEN R., Acar N. P., KHASIYEV F., GÜMELER E., SOYLEMEZOGLU F., et al.Neuroradiology Journal, cilt.31, sa.1, ss.42-46, 2018 (ESCI, Scopus)
  20. Progressive multifocal leukoencephalopathy in a patient with lymphoma and presumptive hyper IgE syndromeGÖÇMEN R., Acar N. P., Cagdas D. N., Kurne A.Journal of NeuroVirology, cilt.23, sa.4, ss.632-636, 2017 (SCI-Expanded, Scopus)
  21. Santral Sensitizasyon-Tanı YöntemleriACAR ÖZEN N. P., ÜNAL ÇEVİK I.Türkiye Klinikleri Journal of Physixal Medicine and Rehabilitation-Special Topics, cilt.10, ss.247-251, 2017 (Hakemli Dergi)
  22. Isolated central nervous system Whipple's disease: Two casesVURAL A., Acar N. P., Soylemezoglu F., Oguz K. K., DERİCİOĞLU N., Saka E.CLINICAL NEUROLOGY AND NEUROSURGERY, cilt.139, ss.91-94, 2015 (SCI-Expanded, Scopus)
  23. Disseminated cystic lesions A case of disseminated oligodendroglial-like leptomeningeal tumorAcar N. P., Oguz K. K., Kurne A. T., NURLU G., Ozer H., Soylemezoglu F.NEUROLOGY, cilt.84, sa.13, ss.1382-1383, 2015 (SCI-Expanded, Scopus)
  24. Two Different Imaging Patterns In A Case With Cerebral Fat EmbolismGÖÇMEN R., ÜNAL E., Acar N. P., ARSAVA E. M.JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, cilt.32, sa.1, ss.188-192, 2015 (SCI-Expanded, Scopus, TRDizin)
  25. Diabetic uremic syndrome studied with cerebral MR spectroscopy and CT perfusionAcar N. P., ARSAVA E. M., GÖÇMEN R., DERİCİOĞLU N., TOPÇUOĞLU M. A.METABOLIC BRAIN DISEASE, cilt.28, sa.4, ss.711-715, 2013 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 9

  1. Comparison of Clinical Features of Aquaporin-4 Positive Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein (MOG) Associated Disorder, and Seronegative NMOSD - A Single Center ExperienceOzbek E. D., ÇAKAN ERCAN M., ACAR ÖZEN N. P., ÇOLPAK IŞIKAY A. İ., KAŞIKCI ÇAVDAR M., KARABUDAK R., et al.9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.660-661, (Özet Bildiri)
  2. Clinical Features, Treatment and Outcomes of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) - An Experience from a Tertiary CenterOzbek E. D., ACAR ÖZEN N. P., GÖÇMEN R., Tan E., KARABUDAK R., TUNCER M. A.9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.654, (Özet Bildiri)
  3. The Effect of Pregnancy on Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Associated Disease Activity and Progression: A Multi-center Retrospective Study from TurkeyUzunkopru C., Şen S., Altintas A., ÇAKAN ERCAN M., BÜNÜL S. D., Demir G. A., et al.9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.664, (Özet Bildiri)
  4. Evaluation of Nutritional Status in Patients with Multiple SclerosisATABİLEN B., AKDEVELİOĞLU Y., ACAR ÖZEN N. P., KARABUDAK R., TUNCER M. A.9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.1043-1044, (Özet Bildiri)
  5. Real World Ocrelizumab Experience of a Tertiary Center in TurkeyARSLAN D., Acar-Ozen N. P., KARABUDAK R., Tuncer A.Virtual Annual Meeting of the American-Academy-of-Neurology, ELECTR NETWORK, 17 - 22 Nisan 2021, cilt.96, (Özet Bildiri)
  6. The Maculo-Papillary Bundle and Inner Ganglion Cell Layer Are Affected More Prominently in Radiologically Isolated SyndromeKARABUDAK R., Vural A., Acar N. P., TUNCER M. A., Sayat G., KADAYIFÇILAR S.9th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Bangkok, Tayland, 27 - 29 Ekim 2016, cilt.23, ss.326, (Özet Bildiri)
  7. Neuroimaging Findings of a Case with Primary LeptomeningealMelanomatosisGÖÇMEN R., ACAR N. P., İNKAYA A. Ç., TUNCER M. A.XXth. Synposium Neuroradiologicum 2014, İstanbul, Türkiye, 7 - 12 Eylül 2014, (Özet Bildiri)
  8. Otoimmün Kökenli Merkezi Sinir Sistemi Hastaliklarinda B Hücrelerin İmmünfenotiplendirilmesiKURAL MANGIT E., TAVUKÇUOĞLU DEMİR E., ACAR ÖZEN N. P., ESENDAĞLI G., TUNCER M. A.
  9. MSMilan 2023 – ePosterDemirel Özbek E., Çakan M., ACAR ÖZEN N. P., ÇOLPAK IŞIKAY A. İ., KAŞIKCI ÇAVDAR M., KARABUDAK R., et al.

İletişim

Bölüm
Nöroloji, Erişkin Hastanesi

Son güncelleme: